Gilead Sciences
GILD
982 hedge funds and large institutions have $97.4B invested in Gilead Sciences in 2013 Q3 according to their latest regulatory filings, with 88 funds opening new positions, 337 increasing their positions, 440 reducing their positions, and 46 closing their positions.
91% more first-time investments, than exits
New positions opened: 88 | Existing positions closed: 46
39% more funds holding in top 10
Funds holding in top 10: 82 → 114 (+32)
20% more capital invested
Capital invested by funds: $81.1B → $97.4B (+$16.3B)
4% more funds holding
Funds holding: 948 → 982 (+34)
23% less repeat investments, than reductions
Existing positions increased: 337 | Existing positions reduced: 440
67% less call options, than puts
Call options by funds: $785M | Put options by funds: $2.37B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OppenheimerFunds
New York
|
+$545M |
| 2 |
MC
Montag & Caldwell
Atlanta,
Georgia
|
+$230M |
| 3 |
Goldman Sachs
New York
|
+$153M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$151M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$132M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
-$397M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$396M |
| 3 |
MCM
Marsico Capital Management
Denver,
Colorado
|
-$291M |
| 4 |
Capital Research Global Investors
Los Angeles,
California
|
-$178M |
| 5 |
SCA
SAC Capital Advisors
Stamford,
Connecticut
|
-$135M |
GILD Hedge Fund Activity: Q3 2013 in Review
982 of the 3,096 institutional investors tracked by Wall St. Rank reported a position in Gilead Sciences (GILD) for Q3 2013, worth a combined $97.4B — up 20% from $81.1B a quarter earlier.
Buyers outnumbered sellers: 88 funds opened new GILD positions and 46 closed out — a net gain of 42 holders — while 337 added to existing stakes and 440 trimmed.
The largest buyer was OppenheimerFunds, adding an estimated $545M. The largest seller was Capital World Investors, cutting an estimated $397M.
- 982 institutional investors held Gilead Sciences (GILD) as of Q3 2013, up from 948 in Q2 2013.
- Funds reported $97.4B of Gilead Sciences stock for Q3 2013, up 20% quarter-over-quarter.
- 88 funds opened new Gilead Sciences positions in Q3 2013 and 46 closed out, a net change of +42 holders.
- The largest Gilead Sciences buyer in Q3 2013 was OppenheimerFunds, an estimated $545M added.
- The largest Gilead Sciences seller in Q3 2013 was Capital World Investors, an estimated $397M sold.
Based on aggregated 13F filings for Q3 2013.